Showing results (2491-2500 of 2,640) with videos related to
Sort By:
Pageof 264
European Urology Focus|July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial CarcinomaStephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.Leukemia|July 12, 2013
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantationE M Weissinger, J Metzger, C Dobbelstein, et al.Journal of Clinical Pathology|September 26, 2000
Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breastA G Douglas-Jones, J M Morgan, M A Appleton, et al.Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.Nature Biotechnology|February 25, 2022
Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populationsTyler E Miller, Caleb A Lareau, Julia A Verga, et al.Journal of Advanced Nursing|April 25, 2022
Nurses' strategies for overcoming barriers to fundamental nursing care in patients with COVID-19 caused by infection with the SARS-COV-2 virus: Results from the 'COVID-NURSE' surveyHolly V R Sugg, David A Richards, Anne-Marie Russell, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
E2 displacement of CIP2A from TOPBP1 activates the DNA damage response during papillomavirus life cyclesApurva T Prabhakar, Claire D James, Allison Q Nguyen, et al.Urology Practice|October 9, 2024
Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based TestingSophia M Abusamra, Marissa A Solorzano, Jake Quarles, et al.European Urology Oncology|April 4, 2021
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate CancerAndi K Cani, Kevin Hu, Chia-Jen Liu, et al.Cancer|September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancerPeter S Kirk, Kehao Zhu, Yingye Zheng, et al.Pageof 264